Furthermore, a growing body of evidence has demonstrated that the Nrf2 signaling pathway can significantly ameliorate CIS-mediated cell and tissue toxicity (Mirzaei et al., 2021). This evidence concerns the gene NFE2L2 and in situ carcinoma.